Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANTITHROMBIN III HUMAN: 92 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
92
Total FAERS Reports
11 (12.0%)
Deaths Reported
32
Hospitalizations
92
As Primary/Secondary Suspect
14
Life-Threatening
1
Disabilities

First Report: 19911104 · Latest Report: 20250101

What Are the Most Common ANTITHROMBIN III HUMAN Side Effects?

#1 Most Reported
Drug ineffective
19 reports (20.7%)
#2 Most Reported
Off label use
17 reports (18.5%)
#3 Most Reported
Prescribed overdose
11 reports (12.0%)

All ANTITHROMBIN III HUMAN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug ineffective 19 20.7% 5 12
Off label use 17 18.5% 1 4
Contraindicated product administered 11 12.0% 1 0
Prescribed overdose 11 12.0% 1 0
Foetal exposure during pregnancy 9 9.8% 1 0
Hepatic function abnormal 7 7.6% 0 7
Hyperglycaemia 7 7.6% 0 7
Premature baby 7 7.6% 0 0
Adenovirus infection 5 5.4% 0 5
Cholestasis 5 5.4% 0 5
Diarrhoea 5 5.4% 0 5
Graft versus host disease 5 5.4% 0 5
Ileus paralytic 5 5.4% 0 5
Low birth weight baby 5 5.4% 0 1
Maternal exposure during pregnancy 5 5.4% 0 3
Pneumothorax 5 5.4% 0 5
Respiratory disorder 5 5.4% 0 5
Shock haemorrhagic 5 5.4% 3 3
Suspected transmission of an infectious agent via product 5 5.4% 0 2
Thrombotic microangiopathy 5 5.4% 0 5

Who Reports ANTITHROMBIN III HUMAN Side Effects? Age & Gender Data

Gender: 80.2% female, 19.8% male. Average age: 34.6 years. Most reports from: US. View detailed demographics →

Is ANTITHROMBIN III HUMAN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2008 1 0 1
2013 6 0 5
2014 3 1 2
2015 2 0 0
2016 1 0 0
2017 3 0 1
2018 1 0 1
2019 5 0 4
2020 1 1 1
2022 3 2 3
2023 1 0 0
2025 1 0 0

View full timeline →

What Is ANTITHROMBIN III HUMAN Used For?

IndicationReports
Prophylaxis 14
Anticoagulant therapy 12
Antithrombin iii deficiency 9
Product used for unknown indication 6
Abnormal clotting factor 5
Foetal exposure during pregnancy 5
Thrombosis prophylaxis 5

Official FDA Label for ANTITHROMBIN III HUMAN

Official prescribing information from the FDA-approved drug label.